James E. Levine Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E. Levine.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E. Levine. James E. Levine is EVP, Chief Financial Officer in VERENIUM CORP ($DVSA) and Chief Financial Officer in Cidara Therapeutics, Inc. ($CDTX).
Latest Insider Trading Transactions of James E. Levine
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | A | 2.55 | 130,000 | 331,500 | 130,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | A | 2.55 | 130,000 | 331,500 | 130,000 | |
| Nov 12 2020 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Buy | P | 2.01 | 50,000 | 100,720 | 50,000 | 0 to 50 K |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | M | 1.98 | 110,000 | 217,800 | 110,000 | |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 61,891 | 36.9 K to 61.9 K (+67.77 %) |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | X | 2.51 | 6,891 | 17,296 | 0 | |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Buy | X | 2.51 | 6,891 | 17,296 | 211,891 | 205 K to 211.9 K (+3.36 %) |
| Sep 26 2019 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Buy | P | 1.91 | 30,000 | 57,240 | 205,000 | 175 K to 205 K (+17.14 %) |
| Sep 26 2019 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Buy | P | 1.91 | 30,000 | 57,240 | 205,000 | 175 K to 205 K (+17.14 %) |
| Dec 04 2018 | CDTX | Cidara Therapeutic ... | Levine James E. | Chief Financial Off ... | Option Exercise | A | 3.62 | 175,000 | 633,500 | 175,000 | |
| Mar 01 2011 | DVSA | VERENIUM CORP | Levine James E. | EVP, Chief Financia ... | Option Exercise | A | 3.31 | 129,695 | 429,290 | 129,695 | |
| Mar 01 2011 | DVSA | VERENIUM CORP | Levine James E. | EVP, Chief Financia ... | Option Exercise | A | 3.31 | 34,796 | 115,175 | 34,796 | |
| Sep 09 2010 | DVSA | VERENIUM CORP | Levine James E. | EVP, Chief Financia ... | Option Exercise | A | 3.04 | 444 | 1,350 | 444 | |
| Sep 09 2010 | DVSA | VERENIUM CORP | Levine James E. | EVP, Chief Financia ... | Option Exercise | A | 3.04 | 84,556 | 257,050 | 84,556 | |
| Aug 17 2010 | DVSA | VERENIUM CORP | Levine James E. | EVP, Chief Financia ... | Buy | P | 2.51 | 25,150 | 63,127 | 54,172 | 29 K to 54.2 K (+86.66 %) |
| Aug 17 2010 | DVSA | VERENIUM CORP | Levine James E. | EVP, Chief Financia ... | Buy | P | 2.50 | 24,856 | 62,140 | 29,022 | 4.2 K to 29 K (+596.64 %) |
| Dec 15 2009 | DVSA | VERENIUM CORP | Levine James E. | EVP, Chief Financia ... | Option Exercise | A | 4.12 | 20,000 | 82,400 | 20,000 | |
| May 27 2009 | DVSA | VERENIUM CORP | Levine James E. | EVP, Chief Financia ... | Option Exercise | A | 0.65 | 250,000 | 162,500 | 250,000 | |
| May 27 2009 | DVSA | VERENIUM CORP | Levine James E. | EVP, Chief Financia ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Page: 1